Drug intelligence / Profile preview

taxane + carboplatin

Development stage
Unknown
Lead developer
Bristol Myers Squibb
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Intravenous
01

Overview

Taxane + carboplatin is a combination chemotherapy regimen consisting of a taxane (most commonly paclitaxel or docetaxel) and carboplatin. This combination is widely used to treat various solid tumors, including ovarian, lung, breast (notably triple-negative and HER2-positive), endometrial (womb), and cervical cancers. Taxanes work by stabilizing microtubules in cancer cells, thereby inhibiting cell division and promoting apoptosis. Carboplatin is a platinum-based agent that causes DNA crosslinking and prevents DNA replication in rapidly dividing cells. The two drugs are typically administered intravenously in cycles every 3–4 weeks. The combination has demonstrated improved efficacy over single-agent therapy or older regimens such as cisplatin-based combinations for certain cancers[1][3][5][6].

Other names
PCCarboTaxolTP regimen
02

Targets

DNATUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on taxane + carboplatin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on taxane + carboplatin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call